May 10, 2021, 01:00 by User Not Found

Clinical Research News | A university’s ability to conduct clinical trials with speed and efficiency has become a key consideration of the National Institutes of Health (NIH) when doling out grants, so the Medical University of South Carolina has created a digital platform called Research Integrated Network of Systems (RINS) to generate the kind of performance benchmarks that can help keep institutions in the running.

May 6, 2021, 01:00 by User Not Found

Clinical Research News | Today’s clinical trial landscape is incredibly complex to navigate. A prevailing issue is inefficiency—relying on years of approved and proven SOPs that can result in expensive delays and increased burdens for patients, sites and sponsors. The good news is disruptive technologies—specifically artificial intelligence—are tangibly resolving challenges inherent to the clinical trial process.

May 3, 2021, 01:00 by User Not Found

Clinical Research News | Mergers and strategic collaborations link data from devices and sensors, streamline research workflows, and aim to accelerate clinical trials. Plus, updated CTMSs, expanded CROs, and more new products and updates from around the industry.

Apr 30, 2021, 01:00 by User Not Found

Clinical Research News | Imaging biomarkers, which are generated through the science of radiomics (think: advanced imaging analytics), are likely to play in the future of personalized drug development. Today, private industry and academia are collaborating on research to discover and develop new imaging biomarkers to add a new layer to the personalization of medicine.

Apr 29, 2021, 01:00 by User Not Found

Clinical Research News | Medable nets cash to deliver decentralized trials; more money for telemedicine and telehealth delivery, investments in healthcare data platforms, and more.

Apr 26, 2021, 01:00 by User Not Found

Clinical Research News | The pandemic has served to highlight the value of real-world evidence (RWE) in personalizing the delivery of care and potentially reducing disparities in access to treatment options, including clinical studies. To explore this “new frontier,” Medable has contracted with Kaiser Permanente to develop mobile apps designed to capture insights from informal caregivers, and digital biomarkers from wearable devices with patients, in fully decentralized trials.

Apr 21, 2021, 01:00 by User Not Found

Clinical Research News | Senescent cells can be good or bad actors when it comes to human health, but their steady accumulation with aging has adverse consequences that pharmaceutical companies are keen on reversing. Determining if a senolytic drug is working in the human body is a tough proposition, however, since the testing process often involves a biopsy and waiting long periods of time to determine whether a pathology has been ameliorated.

Apr 19, 2021, 01:00 by User Not Found

Clinical Research News | When conducting a clinical trial on a global scale, sponsors assume a certain amount of risk in addition to significant management challenges, many of which can be attributed to communication. For this reason, comprehensive translation strategies are important to consider prior to moving forward with a clinical trial.

Apr 15, 2021, 11:00 by

eClinical thought leaders to discuss decentralized trials, digital transformation of clinical research and modernized clinical data infrastructures at upcoming industry events

Apr 15, 2021, 11:00 by

Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in clinical trials

Apr 15, 2021, 11:00 by

Apr 15, 2021, 11:00 by

Global clinical research organization selects eClinical’s elluminate clinical data platform to optimize trial efficiency and speed

Apr 15, 2021, 11:00 by

ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.

Apr 15, 2021, 11:00 by

Apr 15, 2021, 11:00 by

CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has revealed its capabilities of conducting Proof of Concept (PoC) studies and pivotal clinical research for drug development scientists in biological and pharmaceutical institutes and companies.

Apr 15, 2021, 11:00 by

Albumedix Ltd., a recognised global leader in recombinant human albumin specializing in the enablement of advanced therapies, has announced the completed expansion of the company’s commercial-scale manufacturing facility, alongside the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.

Apr 14, 2021, 14:08 by User Not Found

Clinical Research News | Sanofi has succeeded in accelerating its clinical development timeline year over year, in large part by viewing patients as customers and key opinion leaders (KOLs), according to Victoria DiBiaso, vice president and regional head of the clinical studies unit in Asia Pacific, Eurasia, Middle East, and Africa. “What that means for patients is that we are developing meaningful healthcare solutions that are addressing unmet needs and we are doing it faster.”

Apr 13, 2021, 01:00 by User Not Found

Clinical Research News | What are the benefits of Personal Health Records (PHRs) are, not just to patients, but to the wider health system? The most straightforward answer is this: patients who are engaged in their healthcare and understand their condition have better health outcomes. PHRs have a vital role to play in patient empowerment, effective clinical trials, and preventative and precision medicine around the world.

Apr 9, 2021, 01:00 by User Not Found

Clinical Research News | Health equality does not assure health equity, where the focus is on fixing root problems so access to tools and resources is possible across populations, according to Laurie Myers, global health literacy director at Merck.

Apr 8, 2021, 01:00 by User Not Found

Clinical Research News | Social and behavioral science is critical to the generation of real-world evidence (RWE) that reflects the patient perspective, according to Emily Freeman, Ph.D., senior director of patient insights in global R&D at Lundbeck Pharmaceuticals, and generating that evidence requires more multi-disciplinary expertise than is currently being brought to the table.